Evaluating heart involvement in athletes with COVID-19
Hearts of Athletes Study: Prospective Evaluation of Athletes for Cardiac Involvement With COVID-19
This study is testing how COVID-19 affects the heart health of athletes, including college and professional players, by having them share daily health updates and undergo heart check-ups.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 30 Years |
| Sex | All |
| Sponsor | Duke University Academic / other |
| Locations | 1 site (Durham, North Carolina) |
| Trial ID | NCT04736004 on ClinicalTrials.gov |
What this trial studies
The Hearts of Athletes study aims to assess cardiac involvement in athletes diagnosed with COVID-19. It will enroll adult athletes, including NCAA collegiate, professional, military, and Olympic athletes, who have either tested positive for COVID-19 or are identified as local control participants. Participants will use mobile devices to report daily health information and undergo standard cardiovascular evaluations. De-identified cardiac images will be analyzed at the Duke Heart Center to understand the impact of COVID-19 on heart health in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are adult athletes who have been diagnosed with COVID-19 or are willing to serve as control participants.
Not a fit: Patients with known cardiovascular diseases or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the cardiac effects of COVID-19 in athletes, leading to better management and care strategies.
How similar studies have performed: Other studies have explored cardiac effects of COVID-19, but this specific focus on athletes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any adult athlete (defined as NCAA Collegiate Athlete, Professional Athlete, or Olympic Athlete) will be eligible for the study. * COVID-19 diagnosed via an RT-PCR, or history of COVID-19 antibodies at least 10 days and less than 6 months prior to consent * No longer requiring quarantine per local health recommendations, prior to cardiovascular evaluation. * Identification as a Control participant (similar sport) to a participant without COVID-19 willing to undergo cardiovascular evaluation Exclusion Criteria: * Anyone with known cardiovascular disease - defined as known myocardial disease, valvular heart disease, or known coronary heart disease * Anyone without the ability to provide informed consent * Anyone with a known contraindication to cardiac magnetic resonance (metallic implant)
Where this trial is running
Durham, North Carolina
- Duke University — Durham, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Manesh Patel, MD — Duke University
- Study coordinator: Krista Camuglia
- Email: heartsofathletes@duke.edu
- Phone: 919-862-5967
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.